(Total Views: 424)
Posted On: 08/06/2019 10:10:37 PM
Post# of 72443
Novartis subsidiary submits "incomplete" cherry-picked data to get FDA approval before it should have. FDA shrugs.
https://www.washingtonpost.com/health/2019/08...ency-says/
https://www.washingtonpost.com/health/2019/08...ency-says/
(1)
(0)Scroll down for more posts ▼
